Home Cart Sign in  
Chemical Structure| 52549-17-4 Chemical Structure| 52549-17-4

Structure of Pranoprofen
CAS No.: 52549-17-4

Chemical Structure| 52549-17-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pranoprofen is a non-steroidal COX inhibitor with anti-inflammatory effects, used in treatment of ophthalmology.

Synonyms: Y 8004; Pyranoprofen

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pranoprofen

CAS No. :52549-17-4
Formula : C15H13NO3
M.W : 255.27
SMILES Code : CC(C1=CC(CC2=CC=CN=C2O3)=C3C=C1)C(O)=O
Synonyms :
Y 8004; Pyranoprofen
MDL No. :MFCD00866111
InChI Key :TVQZAMVBTVNYLA-UHFFFAOYSA-N
Pubchem ID :4888

Safety of Pranoprofen

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • COX

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 cells 5 µM 24 hours Pranoprofen enhanced Dicer expression and decreased H2O2-induced IL-6 expression Theranostics. 2020 Apr 27;10(13):5749-5762.
CCD-18Co cells 5 µM 24 hours Pranoprofen enhanced Dicer expression and decreased H2O2-induced IL-6 expression Theranostics. 2020 Apr 27;10(13):5749-5762.
FHC cells 5 µM 24 hours Pranoprofen enhanced Dicer expression and decreased H2O2-induced IL-6 expression Theranostics. 2020 Apr 27;10(13):5749-5762.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice BAC-induced dry eye model Intraconjunctival injection 0.1% Twice daily for 14 days To evaluate the therapeutic effect of Pranoprofen in dry eye models, results showed that Pranoprofen improved dry eye symptoms but was less effective than miR-223-3p. Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):1
C57BL/6 mice DSS-induced acute colitis and AOM/DSS-induced chronic colitis-associated tumor model Oral administration in drinking water 16 mg/kg Continuous administration Pranoprofen alleviated colitis and prevented colitis-associated tumorigenesis by upregulating Dicer expression Theranostics. 2020 Apr 27;10(13):5749-5762.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03013959 Keratitis, Herpetic UNKNOWN 2025-09-18 Peking Union Medical College H... More >>ospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100000, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.92mL

0.78mL

0.39mL

19.59mL

3.92mL

1.96mL

39.17mL

7.83mL

3.92mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories